| Autor: |
Barcellini, Wilma, Fattizzo, Bruno, Giannotta, Juri A., Quattrocchi, Luisa, Aydin, Semra, Barone, Federica, Carbone, Cecilia, Pomponi, Fabrizio, Metafuni, Elisabetta, Beggiato, Eloise, Sica, Simona, Di Bona, Eros, Lanza, Francesco, Notaro, Rosario, Iori, Anna P. |
| Předmět: |
|
| Zdroj: |
British Journal of Haematology; Sep2021, Vol. 194 Issue 5, p854-856, 3p |
| Abstrakt: |
Main clinical characteristics of PNH patients affected by SARS-CoV-2 infection are reported in the table. Keywords: paroxysmal nocturnal hemoglobinuria; COVID-19 pneumonia; complement inhibitors EN paroxysmal nocturnal hemoglobinuria COVID-19 pneumonia complement inhibitors 854 856 3 09/02/21 20210901 NES 210901 The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised several concerns regarding patients with haematologic and immune-mediated diseases. As regards the remaining 152 patients without a demonstrated SARS-CoV-2 infection, eight experienced a febrile episode, two haemolytic crises in untreated patients ( I n i = 50), and two a BTH event (101 patients on C5 inhibitor); four patients required transfusion support. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text